Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Eiger BioPharmaceuticals Inc | EIGR | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 1,725 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 1,725 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1,10 - 43,35 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 1,725 | USD |
Finanzwerte EIGR
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| US$ 2,55M | - | - | - | -2,64 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Eiger BioPharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 01.4.2024 | 17:12 | GlobeNewswire Inc. | Eiger BioPharmaceuticals Files for Voluntary Chapter 11.. |
| 11.3.2024 | 21:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 24.1.2024 | 22:59 | Edgar (US Regulatory) | Form 8-K - Current report |
| 18.1.2024 | 23:49 | PR Newswire (US) | Eiger and Partner, AnGes, Receive Approval for Zokinvy®.. |
| 08.1.2024 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.1.2024 | 14:45 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.1.2024 | 14:00 | PR Newswire (US) | Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse.. |
| 11.12.2023 | 22:01 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 04.12.2023 | 12:01 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 01.12.2023 | 22:02 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 24.11.2023 | 12:01 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
| 13.11.2023 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Eiger BioPharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
EIGR Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 2,40 | 2,5977 | 1,66 | 2,08 | 173.571 | -0,675 | -28,13% |
| 3 Monate | 6,09 | 8,2672 | 1,10 | 2,03 | 165.371 | -4,37 | -71,67% |
| 6 Monate | 10,20 | 14,337 | 1,10 | 5,92 | 181.597 | -8,48 | -83,09% |
| 1 Jahr | 33,00 | 43,35 | 1,10 | 16,31 | 300.814 | -31,28 | -94,77% |
| 3 Jahre | 256,80 | 300,639 | 1,10 | 121,97 | 426.852 | -255,08 | -99,33% |
| 5 Jahre | 322,80 | 474,60 | 1,10 | 185,12 | 381.302 | -321,08 | -99,47% |
